[11C]PBR-28

N/A

Report date: 2025/11/25 15:53:50
NME

Base Information

Drug Name[11C]PBR-28
Drug Alias Name11C-PBR-28[11C]PBR-28PBR-28
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionTranslocator protein ligands
TargetsTranslocator protein
Therapy Area/IndicationsCorticobasal degenerationStress Disorders, Post-TraumaticPsychotic Disorders +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalYale UniversityThe University Of Texas Health Science Center At Houston +[9] 
Inactive CompaniesColumbia UniversityNational Institute Of Mental Health (Nimh)
Active IndicationsCorticobasal degenerationStress Disorders, Post-TraumaticPsychotic Disorders +[10] 
Inactive IndicationsAtherosclerosisAmyotrophic Lateral SclerosisBrain Injuries, Traumatic +[5] 

Other Information

ATC CodeN/A
Related LinksN/A